Breaking News

Catalent Launches New OptiDose Design Solution

Aims to help craft the ideal dose form for all stakeholders and optimize the potential of a molecule.

Author Image

By: Kristin Brooks

Managing Editor, Contract Pharma

Catalent has launched its new OptiDose Design Solution, an approach that combines data-driven scientific tools with Catalent’s development expertise led by its scientific advisors. Integrating pharmaceutics, and dose form design target patient characteristics, OptiDose Design Solution aims to help craft the ideal dose form for all stakeholders and optimize the potential of a molecule.   “Taking patient needs and market realities into consideration earlier in the drug development process, along...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters